Cargando…
Skin cancer in solid organ transplant recipients: are mTOR inhibitors a game changer?
While immunosuppressive agents are necessary to prevent the rejection of transplanted organs, and are a great medical success story for protecting against early allograft loss, graft and patient survival over the long term are diminished by side effects from these same drugs. One striking long-term...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332735/ https://www.ncbi.nlm.nih.gov/pubmed/25699174 http://dx.doi.org/10.1186/s13737-014-0022-4 |